Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2023

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • Connected Intelligence
  • AI & Machine Learning
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Genomics
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
AI & Machine Learning with a healthcare IQ.

Artificial intelligence is accelerating opportunities. Realizing the benefits for healthcare requires the right expertise. Together, we can solve the problems of today, and drive the breakthroughs of tomorrow.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
Unlock the power of genomic research.

IQVIA enables genomic research via global access to a network of genomic-clinical data, proprietary technologies that enable federated analytics, and therapeutic area & bioinformatics expertise to help you answer your most pressing research questions.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Blog
Three Key Considerations to Select a Compliance-Centric PSP Provider
Mary Jo Climie, Principal Compliance
Aug 26, 2019
  • Blogs
  • Three Key Considerations to Select a Compliance-Centric PSP Provider

Patient Support Programs can be invaluable tools for Life Sciences companies but monitoring compliance of these programs takes no small investment of resources. Various laws and regulations come into consideration, including the False Claims Act, Anti-Kickback statutes, HIPAA, and other data privacy laws. To successfully manage this complexity, vendor partners must be chosen with the utmost care.

Patient Support Programs (PSPs), though rife with compliance considerations, offer patients with complex disease states meaningful, and frequently essential, services. Through PSPs, manufacturers can act as valuable advisors for both providers and patients to ensure appropriate therapeutic delivery, monitoring and communication as a function of best-in-class disease management. In turn, manufactures can benefit from increased product adherence and utilization.

While polling conducted at the 2019 Canadian Pharmaceutical Compliance Congress indicated that the responsibility for managing PSPs falls across different lines of a manufacturer’s business such as medical affairs or patient advocacy teams, 37% have their operational “home base” in a commercially-focused department. Given risks associated with commercial and promotional activities with both patients and healthcare providers, manufacturers must be sure to recognize and effectively manage potential risk associated with key services offered through a PSP.

With the cross-functional activities found within a PSP, centralized oversight and management of compliance risk is a necessity. There is too much at stake for patients, as well as manufacturers, should any part of the protocol “slip through the cracks.” As the scope of program services becomes broader and more complex, manufacturers often look to partner with specialized providers to manage the operations and associated risks. When building, implementing or assessing a PSP provider, ensure a compliance-centric approach by considering the following three issues:

  1. Patient support often includes a financial component to make sure that a patient has access to important treatment. Financial assistance, if offered, must be compliant with the False Claims Act and Anti-Kickback statutes, as well as industry codes and enforcement activities (including Corporate Integrity Agreements). To that end, having a robust and transparent platform to connect the dots from various different data sources – both internal and external (if a vendor is executing PSP services) – is key.
  2. With a goal to optimally support patients, implementing a PSP represents a significant investment. A good provider should be able to help protect that investment by balancing efficient program operations management with the appropriate oversight and governance necessary to minimize risk to both patients and manufacturers. For example, a robust training plan of a program’s standards and policies should be introduced for patient-facing nurses, therapeutic consultants, and other PSP-associated healthcare professionals. Appropriate testing and monitoring plans should also be in place to ensure adherence to the PSP’s compliance framework.
  3. When implementing Patient Support Programs, manufacturers and their providers should always be looking ahead and beyond current regulatory requirements. Data collection, as well as development, implementation and operation of a PSP, should take into consideration all aspects under the compliance-centric umbrella and be designed to be adaptive and accommodate a changing healthcare landscape or future legislative and regulatory requirements.

By promoting therapeutic continuity and adherence, healthcare providers, insurers and patients can all benefit. To drive your organization’s healthcare outcomes forward, be sure to ask questions around these three key areas before signing on with any compliance technology vendor. They will need an intuitive technology paired with a deep, industry-wide knowledge base that can meet or exceed your oversight and reporting requirements, both now and in the future.

“For more information about IQVIA Commercial Compliance, please e-mail commercialcompliance@iqvia.com or visit our webpage. Our experts leverage the industry’s leading technologies to deliver streamlined processes and improved efficiencies that solve your toughest engagement and transparency challenges. From automating and managing the entire HCP/O contracting lifecycle, to capturing, collecting, and reporting global spend; to planning efficient and compliant HCP meetings and engagements—discover how our solutions can make compliance easier for you.”

Contact Us